Literature DB >> 9563071

The use of pharmacoscintigraphy to elucidate food effects observed with a novel protease inhibitor (saquinavir).

C J Kenyon1, F Brown, G R McClelland, I R Wilding.   

Abstract

PURPOSE: To evaluate mechanistically the effect of food on the absorption and gastrointestinal transit of the protease inhibitor saquinavir.
METHODS: Pharmacoscintigraphic investigation in eight healthy volunteers.
RESULTS: Gastric emptying occurred rapidly in the fasted state with some capsules leaving the stomach prior to disintegration. Unmeasurable plasma concentrations were observed in several subjects when dosed under fasted conditions. Following post-prandial administration the radioactive marker became re-distributed within the stomach contents and consequently slower gastric emptying resulted. Plasma concentrations under fed conditions were measurable up to 12 hrs after administration in seven of the eight subjects. Six of the eight plasma profiles showed secondary peaks at c. 4 hours post-dose; two of which coincided with the gastrocolonic response following ingestion of lunch.
CONCLUSIONS: Bioavailability of saquinavir is significantly improved in the presence of food. Emptying of intact capsules in the fasted state may further reduce bioavailability. In the fed state, capsules disintegrate rapidly and gastric emptying is prolonged which may improve exposure of the drug to target absorption sites. Saquinavir may be absorbed from the colon. Second peaks in the absorption profile can only be attributed to gastrocolonic response following ingestion of a meal in some cases. Increased absorption is more likely to be due to an increase in dissolved drug being available for absorption due to general increased motility and secretion stimulated by ingestion of a meal.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9563071     DOI: 10.1023/a:1011972230829

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

Review 1.  Gamma scintigraphy in the evaluation of pharmaceutical dosage forms.

Authors:  S S Davis; J G Hardy; S P Newman; I R Wilding
Journal:  Eur J Nucl Med       Date:  1992

2.  The influence of volume on gastric emptying.

Authors:  J N HUNT; I MACDONALD
Journal:  J Physiol       Date:  1954-12-10       Impact factor: 5.182

Review 3.  The influence of food on the absorption and metabolism of drugs: an update.

Authors:  L Williams; D P Hill; J A Davis; D T Lowenthal
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Jul-Sep       Impact factor: 2.441

4.  HTLV-III gag protein is processed in yeast cells by the virus pol-protease.

Authors:  R A Kramer; M D Schaber; A M Skalka; K Ganguly; F Wong-Staal; E P Reddy
Journal:  Science       Date:  1986-03-28       Impact factor: 47.728

5.  Transit of pharmaceutical dosage forms through the small intestine.

Authors:  S S Davis; J G Hardy; J W Fara
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

6.  The effect of in-vivo dispersion and gastric emptying on glibenclamide absorption from a novel, rapidly dissolving capsule formulation.

Authors:  J A Ganley; J McEwen; R T Calvert; M C Barker
Journal:  J Pharm Pharmacol       Date:  1984-11       Impact factor: 3.765

7.  Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives.

Authors:  R Pauwels; K Andries; J Desmyter; D Schols; M J Kukla; H J Breslin; A Raeymaeckers; J Van Gelder; R Woestenborghs; J Heykants
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

Review 8.  Current knowledge and future prospects for the use of HIV protease inhibitors.

Authors:  G Moyle; B Gazzard
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

9.  Safety and activity of saquinavir in HIV infection.

Authors:  V S Kitchen; C Skinner; K Ariyoshi; E A Lane; I B Duncan; J Burckhardt; H U Burger; K Bragman; A J Pinching; J N Weber
Journal:  Lancet       Date:  1995-04-15       Impact factor: 79.321

10.  Dynamics of the enterohepatic circulation of bile acids. Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption.

Authors:  N F LaRusso; M G Korman; N E Hoffman; A F Hofmann
Journal:  N Engl J Med       Date:  1974-10-03       Impact factor: 91.245

View more
  6 in total

Review 1.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Multiple peaking phenomena in pharmacokinetic disposition.

Authors:  Neal M Davies; Jody K Takemoto; Dion R Brocks; Jaime A Yáñez
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

3.  The effect of cross-linking on the in vivo disintegration of hard gelatin capsules.

Authors:  J Brown; N Madit; E T Cole; I R Wilding; D Cadé
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

4.  Meal composition effects on the oral bioavailability of indinavir in HIV-infected patients.

Authors:  P L Carver; D Fleisher; S Y Zhou; D Kaul; P Kazanjian; C Li
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

Review 5.  Effects of food on clinical pharmacokinetics.

Authors:  B N Singh
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

6.  Enhanced saquinavir exposure in human immunodeficiency virus type 1-infected patients with diarrhea and/or wasting syndrome.

Authors:  Hervé Trout; France Mentré; Xavière Panhard; Alissi Kodjo; Lélia Escaut; Pascal Pernet; Jean-Gérard Gobert; Daniel Vittecoq; Anne-Laure Knellwolf; Charles Caulin; Jean-François Bergmann
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.